{"id":484120,"date":"2021-04-29T07:33:23","date_gmt":"2021-04-29T11:33:23","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\/"},"modified":"2021-04-29T07:33:23","modified_gmt":"2021-04-29T11:33:23","slug":"achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\/","title":{"rendered":"Achiko\u2019s Joint Venture Partner Obtains a Distribution Certificate for AptameX, a Novel Diagnostic Test for Covid-19 in Indonesia, and Commences Product Registration"},"content":{"rendered":"<div class=\"mw_release\">\n<ul>\n<li style=\"text-align:left\">Achiko AG\u2019s Joint Venture Partner PT Indonesia Farma Medis (IFM) Obtains Medical Device Distribution Certificate\n<\/li>\n<li>Achiko Subsequently Commenced Product Registration with its Partners with a View to Mid-Year Commercial Product Availability\n<\/li>\n<li>Achiko to Generate Revenues on a 50% Holding of the Joint Venture and a 10% Licensing Fee from Gross Sales<\/li>\n<\/ul>\n<p align=\"justify\">ZURICH, Switzerland, April  29, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=e5YbSa5lJflulXDJDvRCFSoMm8FHe8AXZIpCxZnJBSZUxe2QV9JrPrnzOmm_kCxQ7SnlVwkdLUsre7kb4eDp3g==\" rel=\"nofollow noopener\" target=\"_blank\">Achiko AG\u2019s<\/a> (SWX:ACHI, ISIN CH0522213468) joint venture partner <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qp-asqnZhraiPl9lmeZNmNGPYK-W9THIcYgaK8jOIWc7v0tGgkHb3AVhOz1Ri_HlQ3QLtTcxEqgI485LJE52nLPps6OFTV55djtBsyj-ea4=\" rel=\"nofollow noopener\" target=\"_blank\">PT Indonesia Farma Medis<\/a> (\u201cIFM\u201d) has been granted a medical device distribution certificate for Indonesia and commences product registration for AptameX.<\/p>\n<p align=\"justify\">This certificate will allow for the procurement, storage and distribution of the novel diagnostic test, AptameX (formerly Project Gumnuts) in Indonesia. It establishes the foundation for a subsequent product registration facilitating the production and sales of the product in Indonesia. Achiko has subsequently commenced product registration with its partners with a view to a mid-year commercial product availability.<\/p>\n<p align=\"justify\">To this end, Achiko and IFM are progressing forward with the establishment of the joint venture company PT Achiko Medika Indonesia for the production, distribution and marketing of AptameX (formerly Project Gumnuts) in Indonesia. Achiko will realize revenues on a 50% holding and earn a 10% licensing fee from gross sales.<\/p>\n<p align=\"justify\">Indonesia is a significant and important market, with over 270 million people spread over 16,000 islands. The joint venture meets local ownership and approval requirements, enabling Achiko\u2019s solution to provide security for millions of Indonesians\u2019 lives through facilitating access to several tests a month, each at an affordable price.<\/p>\n<p align=\"justify\">For shareholders, this translates to licensing and profit share incomes from the joint venture established with IFM.<\/p>\n<p align=\"justify\">\n        <strong>ABOUT ACHIKO AG<\/strong><br \/>\n        <br \/>Achiko creates and develops new innovations in healthcare technology through its biotechnology division, AptameX, and its sister digital mobile health technology division, Teman Sehat. The Company has created a unique telehealth capability that provides user-friendly diagnostic testing integrated with a digital passport solution for the management of Covid-19.<\/p>\n<p align=\"justify\">AptameX comprises of DNA aptamer-based technology that is cost-effective, chemically synthesized and widely applicable to the evolving diagnostic field of healthcare. Together with the digital mobile health app Teman Sehat, Achiko is developing potential technologies that seek to deliver rapid, affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications. The AptameX technology is licensed from Regenacellx.sl and Achiko has exclusive commercialization rights.<\/p>\n<p align=\"justify\">Headquartered in Zurich, Achiko has offices in Hong Kong, Jakarta, Seoul and Singapore.<\/p>\n<p align=\"justify\">Further information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0-NOaOIVdVXh0qWZssHw4ioc6ENq0K0OP8HhX0g7BN937qlOvIXFPAQhc_lBySjcXMBLJ3cDhbnrxkZ7TIplwg==\" rel=\"nofollow noopener\" target=\"_blank\">www.achiko.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>ABOUT PT INDONESIA FARMA MEDIS<\/strong><br \/>\n        <br \/>PT Indonesia Farma Medis (\u201cIFM\u201d) is a medical device and pharmaceutical distribution company with a large network of relationships and distribution channels\u00a0that includes hospitals, pharmacies and clinics across the main islands of Indonesia.<\/p>\n<p align=\"justify\">IFM provides supply chain solutions for distributing medical products and helps companies seeking market entry navigate the complexities of the Indonesian market. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8JLzqq8lhyxgxJHTN_B6029E7-q9ooN4-JQzth9iD15g7-pQ4bDmUKT4XuICvwewqXecrrgkt_Vy4oQOIDisVnLJrVg12VZeOloxXk3SNUU=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/indofarmamedis.com<\/a><\/p>\n<p>\n        <strong>Media contacts: <\/strong>\n      <\/p>\n<p>\n        <strong>ACHIKO AG<\/strong><br \/>\n        <br \/>Investor Relations<br \/>E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZJAQOr04sniyL_tsMpXJ1GSKaigT5uiB794ERhIlsOa_Ib7wPt7okQ_XzWcQ8Gau5TMEm0et7tWdQ6Yx_XdPRQ==\" rel=\"nofollow noopener\" target=\"_blank\">ir@achiko.com<\/a><\/p>\n<p>\n        <strong>Switzerland<\/strong><br \/>\n        <br \/>Marcus Balogh<br \/>Farner Consulting Ltd.<br \/>E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dug2D8FTzKttD67rNKsUZ-41DIt-wu756Pady9bE73O7NxyY1UcvROoIwTKZ4EyPyLgRAb2FoBc2T9wcRk0xlA==\" rel=\"nofollow noopener\" target=\"_blank\">achiko@farner.ch<\/a><br \/>T: +41 44 266 67 67<\/p>\n<p>\n        <strong>Germany and Austria<\/strong><br \/>\n        <br \/>Axel M\u00fchlhaus \/ Dr S\u00f6nke Knop<br \/>edicto GmbH<br \/>E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dug2D8FTzKttD67rNKsUZ00rVM8WtbgdBSxaH34Wsh96lidtWIK_88O3Ha1MODWBFjcIFyBmY172Co92sZtbbw==\" rel=\"nofollow noopener\" target=\"_blank\">achiko@edicto.de<\/a><br \/>T: +49 69 90 55 05-51<\/p>\n<p align=\"justify\">\n        <strong>DISCLAIMER<\/strong><br \/>\n        <br \/>\n        <em>This communication expressly or implicitly contains certain forward-looking statements concerning Achiko AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of Achiko AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Achiko AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.<\/em>\n      <\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTY2MCM0MTQ0NDY5IzIyMDI3NDA=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/a38648e8-0675-4113-803d-33a0f36877cd\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Achiko AG\u2019s Joint Venture Partner PT Indonesia Farma Medis (IFM) Obtains Medical Device Distribution Certificate Achiko Subsequently Commenced Product Registration with its Partners with a View to Mid-Year Commercial Product Availability Achiko to Generate Revenues on a 50% Holding of the Joint Venture and a 10% Licensing Fee from Gross Sales ZURICH, Switzerland, April 29, 2021 (GLOBE NEWSWIRE) &#8212; Achiko AG\u2019s (SWX:ACHI, ISIN CH0522213468) joint venture partner PT Indonesia Farma Medis (\u201cIFM\u201d) has been granted a medical device distribution certificate for Indonesia and commences product registration for AptameX. This certificate will allow for the procurement, storage and distribution of the novel diagnostic test, AptameX (formerly Project Gumnuts) in Indonesia. It establishes the foundation for a subsequent product registration facilitating the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Achiko\u2019s Joint Venture Partner Obtains a Distribution Certificate for AptameX, a Novel Diagnostic Test for Covid-19 in Indonesia, and Commences Product Registration&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-484120","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Achiko\u2019s Joint Venture Partner Obtains a Distribution Certificate for AptameX, a Novel Diagnostic Test for Covid-19 in Indonesia, and Commences Product Registration - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Achiko\u2019s Joint Venture Partner Obtains a Distribution Certificate for AptameX, a Novel Diagnostic Test for Covid-19 in Indonesia, and Commences Product Registration - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Achiko AG\u2019s Joint Venture Partner PT Indonesia Farma Medis (IFM) Obtains Medical Device Distribution Certificate Achiko Subsequently Commenced Product Registration with its Partners with a View to Mid-Year Commercial Product Availability Achiko to Generate Revenues on a 50% Holding of the Joint Venture and a 10% Licensing Fee from Gross Sales ZURICH, Switzerland, April 29, 2021 (GLOBE NEWSWIRE) &#8212; Achiko AG\u2019s (SWX:ACHI, ISIN CH0522213468) joint venture partner PT Indonesia Farma Medis (\u201cIFM\u201d) has been granted a medical device distribution certificate for Indonesia and commences product registration for AptameX. This certificate will allow for the procurement, storage and distribution of the novel diagnostic test, AptameX (formerly Project Gumnuts) in Indonesia. It establishes the foundation for a subsequent product registration facilitating the &hellip; Continue reading &quot;Achiko\u2019s Joint Venture Partner Obtains a Distribution Certificate for AptameX, a Novel Diagnostic Test for Covid-19 in Indonesia, and Commences Product Registration&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-29T11:33:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTY2MCM0MTQ0NDY5IzIyMDI3NDA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Achiko\u2019s Joint Venture Partner Obtains a Distribution Certificate for AptameX, a Novel Diagnostic Test for Covid-19 in Indonesia, and Commences Product Registration\",\"datePublished\":\"2021-04-29T11:33:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\\\/\"},\"wordCount\":615,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTY2MCM0MTQ0NDY5IzIyMDI3NDA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\\\/\",\"name\":\"Achiko\u2019s Joint Venture Partner Obtains a Distribution Certificate for AptameX, a Novel Diagnostic Test for Covid-19 in Indonesia, and Commences Product Registration - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTY2MCM0MTQ0NDY5IzIyMDI3NDA=\",\"datePublished\":\"2021-04-29T11:33:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTY2MCM0MTQ0NDY5IzIyMDI3NDA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTY2MCM0MTQ0NDY5IzIyMDI3NDA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Achiko\u2019s Joint Venture Partner Obtains a Distribution Certificate for AptameX, a Novel Diagnostic Test for Covid-19 in Indonesia, and Commences Product Registration\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Achiko\u2019s Joint Venture Partner Obtains a Distribution Certificate for AptameX, a Novel Diagnostic Test for Covid-19 in Indonesia, and Commences Product Registration - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\/","og_locale":"en_US","og_type":"article","og_title":"Achiko\u2019s Joint Venture Partner Obtains a Distribution Certificate for AptameX, a Novel Diagnostic Test for Covid-19 in Indonesia, and Commences Product Registration - Market Newsdesk","og_description":"Achiko AG\u2019s Joint Venture Partner PT Indonesia Farma Medis (IFM) Obtains Medical Device Distribution Certificate Achiko Subsequently Commenced Product Registration with its Partners with a View to Mid-Year Commercial Product Availability Achiko to Generate Revenues on a 50% Holding of the Joint Venture and a 10% Licensing Fee from Gross Sales ZURICH, Switzerland, April 29, 2021 (GLOBE NEWSWIRE) &#8212; Achiko AG\u2019s (SWX:ACHI, ISIN CH0522213468) joint venture partner PT Indonesia Farma Medis (\u201cIFM\u201d) has been granted a medical device distribution certificate for Indonesia and commences product registration for AptameX. This certificate will allow for the procurement, storage and distribution of the novel diagnostic test, AptameX (formerly Project Gumnuts) in Indonesia. It establishes the foundation for a subsequent product registration facilitating the &hellip; Continue reading \"Achiko\u2019s Joint Venture Partner Obtains a Distribution Certificate for AptameX, a Novel Diagnostic Test for Covid-19 in Indonesia, and Commences Product Registration\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-29T11:33:23+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTY2MCM0MTQ0NDY5IzIyMDI3NDA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Achiko\u2019s Joint Venture Partner Obtains a Distribution Certificate for AptameX, a Novel Diagnostic Test for Covid-19 in Indonesia, and Commences Product Registration","datePublished":"2021-04-29T11:33:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\/"},"wordCount":615,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTY2MCM0MTQ0NDY5IzIyMDI3NDA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\/","name":"Achiko\u2019s Joint Venture Partner Obtains a Distribution Certificate for AptameX, a Novel Diagnostic Test for Covid-19 in Indonesia, and Commences Product Registration - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTY2MCM0MTQ0NDY5IzIyMDI3NDA=","datePublished":"2021-04-29T11:33:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTY2MCM0MTQ0NDY5IzIyMDI3NDA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTY2MCM0MTQ0NDY5IzIyMDI3NDA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achikos-joint-venture-partner-obtains-a-distribution-certificate-for-aptamex-a-novel-diagnostic-test-for-covid-19-in-indonesia-and-commences-product-registration\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Achiko\u2019s Joint Venture Partner Obtains a Distribution Certificate for AptameX, a Novel Diagnostic Test for Covid-19 in Indonesia, and Commences Product Registration"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/484120","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=484120"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/484120\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=484120"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=484120"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=484120"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}